Dechra Brand Guidelines

Z Y C O R T A L ® HIDDEN DISEASE. VISIBLE ANSWER.

To maintain a strong brand identity, we need a few simple rules.

Zycortal is a prolonged-release suspension used as replacement therapy for mineralocorticoid deficiency in dogs with hypoadrenocorticism (Addison’s Disease). Z Y C O R T A L ® HIDDEN DISEASE. VISIBLE ANSWER.

04 Welcome to the brand 05 Our key brand insight

07 Logo sizes & colours 08 Clear zone 09 Logo grid & positioning line 10 Zycortal & Dechra logo 11 Addison’s Aware logo

The next few pages show examples of the brand in action - all consistent, all impactful and all sticking to the rules.

Z Y C O R T A L ® HIDDEN DISEASE. VISIBLE ANSWER.

Key features:

• Zycortal is the only veterinary registered treatment for Addison’s disease in dogs in Europe • Zycortal contains DOCP, which controls serum electrolytes more effectively than fludrocortisone • A prolonged release suspension for injection provides the confidence that Addison’s disease will be controlled for approximately a month • Individual dose optimisation for mineralocorticoid and glucocorticoid supplementation allows optimal control and reduces the risk of unwanted side effects

14 Colour palette

16 Typeface

18 Tone of voice

20 Photography

24 Application style

30 Brand checklist

• Long-term administration allows long-term control of Addison’s disease

• Dogs treated with Zycortal can go on to live a long and happy life

This document is for internal use only.

2

3